Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. (Q43270300)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. |
scientific article published in October 2009 |
Statements
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes (English)
Nicole C Goodwin
Ross Mabon
Bryce A Harrison
Melanie K Shadoan
Zheng Y Almstead
Yiling Xie
Jason Healy
Lindsey M Buhring
Christopher M DaCosta
Jennifer Bardenhagen
Faika Mseeh
Qingyun Liu
Amr Nouraldeen
Alan G E Wilson
S David Kimball